Search Results for “EC” – Page 154 – media

Spark Therapeutics Enters into a Licensing and Supply Agreement for Investigational Voretigene Neparvovec Outside the U.S.

Spark Therapeutics (ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced it has entered into a licensing agreement with Novartis Pharmaceuticals to develop and commercialize investigational voretigene neparvovec outside the U.S.
- Source: finance.yahoo
- 529
- January 26, 2018
Gene therapy Market Views voretigene neparvovec
Apple looking at easy access to your complete medical records

Chronic diseases and health conditions are often incurable and can adversely impact the longevity and quality of a person’s life if not managed actively. The wide prevalence of these conditions along with the fact that they are often preventable and frequently manageable with early detection and with the right health practices, calls for more focus on empowering patients in ongoing self-care.
- Source: Business Insider
- 708
- January 25, 2018
Apple Company Insight EHR health IT
Shares of biotech Juno, already up 50% on deal hopes, skyrocket on actual Celgene $9 billion offer

Celgene agreed on Monday to buy the rest of Juno Therapeutics it doesn't already own for about $9 billion in cash to gain access to Juno's pipeline of CAR-T cancer drugs.
- Source: Cnbc
- 977
- January 24, 2018
cancer CAR–T Market Views
The Effects Of Air Pollution On Human Health

Although it isn’t talked about often, older adults in the United States are turning to drugs and alcohol at an alarming rate. Studies have found that a large population of older Americans are suffering from substance use disorders, and the number is only expected to rise. According to research, the number of Americans aged 50 and older struggling with addiction is expected to nearly double in the coming years, going from 2.8 million to 5.7 million by 2020.
- Source: msn
- 1,036
- January 24, 2018
air pollution asthma cardiovascular pneumonia
Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C– a systematic review and meta-analysis

Direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection might pose a risk for hepatitis B virus (HBV) reactivation in patients coinfected with chronic or resolved HBV infection. The need for HBV antiviral prophylaxis during DAA treatment remains controversial. We aimed to analyse the absolute risk of HBV reactivation in patients with active or resolved HBV infection treated with DAAs for HCV infection.
- Source: Thelancet
- 501
- January 24, 2018
DAA HBV HCV Researches
‘Explosive evolution’ of techniques to restore blood flow to the brain

Recent decades have seen an "explosive evolution" of techniques to restore blood flow to areas of the brain endangered by stroke or clogged arteries, according to a report by Loyola Medicine neurologists and neurosurgeons.
- Source: Science Daily
- 669
- January 24, 2018
brain medical device Researches stroke surgery
IoT devices vulnerable to Spectre and Meltdown exploitation

Healthcare organizations should use risk management processes to ensure the security of health information and protect against the vulnerabilities stemming from the Spectre and Meltdown threats.
- Source: Healthcare IT News
- 516
- January 23, 2018
healthcare technology Internet of Things Market Views medical device
Pandion Therapeutics Announces $58 Million Series A Financing to Advance Tissue-Specific Immune Modulator Drugs

Pandion Therapeutics, Inc., a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation, today announced the completion of a $58 million Series A financing. This funding will be used to advance its initial drug programs for autoimmune and inflammatory diseases toward the clinic, as well as to continue building the company’s technology platform and pipeline. Polaris Partners, the founding investor that provided the initial seed funding, co-led the Series A financing along with Versant Ventures and Roche Venture Fund. SR One and BioInnovation Capital also participated in the round.
- Source: finance.yahoo
- 887
- January 22, 2018
antibody Company Insight immunomodulation
Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to advance public health measures.
- Source: medicalxpress
- 669
- January 22, 2018
smallpox synthetic DNA synthetic virus vaccine
Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers

Findings In this population-based cohort study of more than 100, 000 predominantly postmenopausal women, risk reductions for ovarian cancer associated with increasing duration of oral contraceptive use were generally consistent across health behaviors. For endometrial cancer, the reductions were strongest among current smokers, obese women, and those who exercised rarely; lack of associations with breast and colorectal cancer were consistent across health behaviors.
- Source: Jamanetwork
- 510
- January 22, 2018
cancer oral contraceptive use Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.